helped them experience less pain during labor. 33% of patients reported that VR was more helpful earlier on until the contractions became very painful. 77% of patients reported that they would want to use it again during a future labor. CONCLUSION: This study shows promise that immersive virtual reality use in labor can decrease pain and potentially decrease the use of IV pain medication to allow an improved experience for women during labor. A larger follow up study is planned. Subjective data from patient surveys suggests a positive effect of VR on the patient experience of pain, particularly during latent labor. Successful external cephalic version (ECV) can reduce the rates of non-cephalic delivery and cesarean section (CS), but does not lack complications.
A Novel prediction model for external cephalic version success
Tal Cahan 1,2 , Maya Shats OBJECTIVE: Breech presentation accounts for 3% to 4% of term pregnancies. Breech vaginal delivery has become less accepted following the publication of the Term Breech Trial in 2000.
Successful external cephalic version (ECV) can reduce the rates of non-cephalic delivery and cesarean section (CS), but does not lack complications.
Poster Session IV ajog.org Currently, maternal consultation on ECV success is limited to quoted success rates, varying from 35-83% in different studies.
Clinical predictive factors have been identified for successful ECV, but have yet to be integrated in a predictive model, potentially assisting in the precise counselling of gravidas with non-cephalic presentation. STUDY DESIGN: A case-control study of patients who underwent ECV from January 2011 to July 2018, at a single tertiary center.
Successful ECV was compared in a single and multivariate analysis using demographic and clinical independent variables to failed ECV group.
A model predicting ECV success algorithm was assembled based on probability calculations extracted from the multivariate analysis. RESULTS: 701 women underwent ECV during the study period. ECV success rate was 60.34%.
Characteristics of success & failure groups are shown on Table 1 . Complication rate was 7.7% (n¼54), of which 77.7% (n¼42) were transient changes in fetal heart rate, 0.28% (n¼2) suspected abruption and one case of neonatal anemia following ECV. Emergency post procedural CS rate was 1.2%.
There were no cases of fetal demise. Positive predictors of successful ECV were Parity 1 (RR¼4.55, CI 3.19-6.49), AFI200mm (RR¼2.4, CI 1.33-4.46). Anterior placentation and maternal weight 70 kg were found to be negative predictors (RR¼0.34, CI 0.236-0.479 and RR¼0.59, CI 0.41-0.85 respectively).
Subsequently a prediction algorithm was built on probability calculations based on the 4 predictors of ECV success; parity (0 or 1), AFI (<100, 100-200, >200), placentation (anterior, nonanterior) and maternal weight (<70kg, 70 kg).
Use of the predictive model enabled excellent prediction of patient specific ECV success rates from 7% up to 95%. CONCLUSION: An algorithm for prediction of successful ECV based on clinical maternal parameters is presented.
Use of this model for calculating expected success rates, could assist in counselling gravidas with breech presentation. Verification of the model in a large scale prospective study is planned.
Oxytocin regimen for induction of labor and pregnancy outcomes
Uma Reddy for the Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network, Bethesda, MD OBJECTIVE: Uncertainty exists regarding the optimal oxytocin dose regimen for induction of labor (IOL). We evaluated the association of oxytocin regimen for IOL with cesarean delivery and with adverse perinatal composite outcome in low-risk nulliparous women. STUDY DESIGN: Secondary analysis of a multi-center randomized control trial of IOL at 39 weeks compared with expectant management in low-risk nulliparous women. Women in either group who underwent IOL with a mid-to high-dose oxytocin (MHD) regimen were compared with those induced with a low-dose oxytocin (LD) regimen. The primary outcomes were cesarean delivery and a composite of perinatal death or severe neonatal complications (Table  1) . M ultivariable regression was used to estimate relative risks (RR) controlling for related covariates, although site could not be adjusted for given collinearity with oxytocin regimen. Interaction between oxytocin regimen and modified Bishop score, induction indication and treatment group were also evaluated. RESULTS: Of 6,106 women enrolled in the primary trial, 3,034 women underwent induction with oxytocin; 889 in the MHD group and 2145 in the LD group. There was a shorter duration from start of oxytocin to delivery (median 11.7 hours vs. 13.4 hours) and higher percentage of women in the lowest quartile for time to delivery in
